SI9720023A - Nova asimetrična sinteza R-alfa-propil-piperonil amina in njegovih analogov - Google Patents

Nova asimetrična sinteza R-alfa-propil-piperonil amina in njegovih analogov Download PDF

Info

Publication number
SI9720023A
SI9720023A SI9720023A SI9720023A SI9720023A SI 9720023 A SI9720023 A SI 9720023A SI 9720023 A SI9720023 A SI 9720023A SI 9720023 A SI9720023 A SI 9720023A SI 9720023 A SI9720023 A SI 9720023A
Authority
SI
Slovenia
Prior art keywords
compound
acid
temperature
alcohol
hours
Prior art date
Application number
SI9720023A
Other languages
English (en)
Slovenian (sl)
Inventor
Hui-Yin Li
Luigi Anzalone
Robert Eugene Waltermire
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of SI9720023A publication Critical patent/SI9720023A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI9720023A 1996-03-22 1997-03-17 Nova asimetrična sinteza R-alfa-propil-piperonil amina in njegovih analogov SI9720023A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1395596P 1996-03-22 1996-03-22
PCT/US1997/003466 WO1997034887A1 (en) 1996-03-22 1997-03-17 NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS

Publications (1)

Publication Number Publication Date
SI9720023A true SI9720023A (sl) 1999-04-30

Family

ID=21762727

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720023A SI9720023A (sl) 1996-03-22 1997-03-17 Nova asimetrična sinteza R-alfa-propil-piperonil amina in njegovih analogov

Country Status (23)

Country Link
US (1) US5932749A (no)
EP (1) EP0888329A1 (no)
JP (1) JP2000506891A (no)
KR (1) KR20000064735A (no)
CN (1) CN1218463A (no)
AR (1) AR006521A1 (no)
AU (1) AU719633B2 (no)
BR (1) BR9708233A (no)
CA (1) CA2249401A1 (no)
CZ (1) CZ295098A3 (no)
EA (1) EA001207B1 (no)
EE (1) EE9800299A (no)
HR (1) HRP970165A2 (no)
IL (1) IL126223A0 (no)
LT (1) LT4540B (no)
LV (1) LV12259B (no)
NO (1) NO984344D0 (no)
NZ (1) NZ331875A (no)
PL (1) PL329070A1 (no)
SI (1) SI9720023A (no)
SK (1) SK127398A3 (no)
WO (1) WO1997034887A1 (no)
ZA (1) ZA972342B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012474A1 (en) 1998-08-31 2000-03-09 Du Pont Pharmaceuticals Company An efficient process for the preparation of a human leukocyte elastase inhibitor
PL372705A1 (en) * 2001-09-12 2005-07-25 Anormed Inc. Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
EA022785B8 (ru) * 2008-12-15 2016-06-30 Тайджен Байотекнолоджи Ко., Лтд. Стереоселективный синтез производных пиперидина
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
US9126906B2 (en) 2012-02-21 2015-09-08 Celgene Corporation Asymmetric synthetic processes for the preparation of aminosulfone compounds
US10953003B2 (en) 2015-12-14 2021-03-23 X4 Pharmaceuticals, Inc. Methods for treating cancer
CA3008279A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
SI3393468T1 (sl) 2015-12-22 2023-01-31 X4 Pharmaceuticals, Inc. Postopki za zdravljenje bolezni imunske pomanjkljivosti
US11337969B2 (en) 2016-04-08 2022-05-24 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3808748A1 (en) 2016-06-21 2021-04-21 X4 Pharmaceuticals, Inc. Substituted piperidines as cxcr4-inhibitors
US11332470B2 (en) 2016-06-21 2022-05-17 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
JP7084624B2 (ja) 2016-06-21 2022-06-15 エックス４ ファーマシューティカルズ， インコーポレイテッド Ｃｘｃｒ４阻害剤およびその使用
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
WO2023034510A1 (en) 2021-09-01 2023-03-09 ATAI Life Sciences AG Synthesis of mdma or its optically active ( r)- or ( s)-mdma isomers
EP4401725A1 (en) * 2021-09-17 2024-07-24 atai Life Sciences AG Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts
US11845736B2 (en) 2021-10-01 2023-12-19 Empathbio, Inc. Prodrugs of MDMA, MDA, and derivatives thereof
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819438A1 (de) * 1987-06-30 1989-01-19 Basf Ag Verfahren zur herstellung von optisch aktiven 1-arylethylaminen
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
US5149838A (en) * 1991-09-20 1992-09-22 Merck & Co., Inc. Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
KR20000064735A (ko) 2000-11-06
EE9800299A (et) 1999-06-15
HRP970165A2 (en) 1998-04-30
BR9708233A (pt) 2000-01-04
CN1218463A (zh) 1999-06-02
EA001207B1 (ru) 2000-12-25
NO984344L (no) 1998-09-18
ZA972342B (en) 1998-09-18
AU719633B2 (en) 2000-05-11
CA2249401A1 (en) 1997-09-25
LT98132A (en) 1999-03-25
PL329070A1 (en) 1999-03-15
AR006521A1 (es) 1999-09-08
US5932749A (en) 1999-08-03
JP2000506891A (ja) 2000-06-06
WO1997034887A1 (en) 1997-09-25
CZ295098A3 (cs) 1999-03-17
EA199800844A1 (ru) 1999-02-25
LT4540B (lt) 1999-08-25
EP0888329A1 (en) 1999-01-07
NZ331875A (en) 2000-01-28
NO984344D0 (no) 1998-09-18
AU2196897A (en) 1997-10-10
SK127398A3 (en) 1999-04-13
IL126223A0 (en) 1999-05-09
LV12259A (lv) 1999-04-20
LV12259B (en) 1999-09-20

Similar Documents

Publication Publication Date Title
SI9720023A (sl) Nova asimetrična sinteza R-alfa-propil-piperonil amina in njegovih analogov
US5545745A (en) Enantioselective preparation of optically pure albuterol
JP4994427B2 (ja) ピクテ−スペングラー反応の変法およびその産物
US4851537A (en) Process for preparing N-acyltetrahydroisoquinoline
US4319040A (en) Process for the production of optically active threo-3-(3,4-dihydroxyphenyl)serine
JPWO2003097632A1 (ja) プロパノールアミン誘導体、及び３−ｎ−メチルアミノ−１−（２−チエニル）−１−プロパノールの製造方法、並びにプロパノールアミン誘導体の製造方法
US7482489B2 (en) Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof
JP2009534385A (ja) キラル的に純粋なアミノアルコール中間体、それらの誘導体の製造、及びそれらの使用
JPH0623150B2 (ja) 光学活性３−ヒドロキシブタン酸類の製造方法
JP3209041B2 (ja) 光学分割剤およびそれを用いた光学活性テトラヒドロフランカルボン酸類の製造法
FI80261C (fi) Foerfarande foer optisk upploesning av en blandning av enantiomerer av trans-3-/(4-metoxifenoxi)-metyl/-1-metyl-4- fenylpiperidin.
JP5406194B2 (ja) Ｒ−ゴシポールｌ−フェニルアラニノールジエナミンを調製するための方法
US6479702B1 (en) 3-amino-1-indanole, method of synthesizing the same and method of optical resolution
JPH10218847A (ja) タートラニル酸の製造法
US20240239791A1 (en) Processes for the synthesis of valbenazine
RU2741389C1 (ru) Способ получения промежуточного соединения для синтеза лекарственного средства
US5334766A (en) Process for the resolution of racemic diphosphine oxides
JP4205130B2 (ja) トレミフェン結晶化法
KR101974388B1 (ko) 알킬 디에틸렌 트리아민 유도체 및 이의 제조방법
EP0780358B1 (en) A process for the resolution of 6-methoxy-alpha-methyl-2-naphthaleneacetic racemic acid into its enantiomers
MXPA98007673A (en) New asymmetric synthesis of r-alpha-propil-piperonil amine and its analo
HU202481B (en) Process for producing n-phenyl-n-(methoxyacetyl)-dl-alanine methyl ester derivatives
JP2002187875A (ja) 光学活性な２−アミノ−５−メトキシテトラリンの製造方法